R&D Lunch and Learn Series 2022 - October 18 Recap - Tabula Rasa HealthCare

Home > R&D Lunch and Learn Series 2022

R&D Lunch and Learn Webinar Recap – October 18

A Deprescribing Approach to Older Adults with Polypharmacy: Addressing Anticholinergic Drug Risk

Medications with anticholinergic properties lead to higher health risk in older adults, especially those taking multiple medications. In this webinar, TRHC’s Clinical Research Scientist Sweilem B. Al Rihani, PharmD, PhD, and Research Pharmacist David Bankes, PharmD, BCGP, discuss the different deprescribing approaches for strong anticholinergic drugs, specifically urinary antimuscarinics (UAMs), in this population.

Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4